Dianthus Therapeutics | 10-Q:季度报表
Dianthus Therapeutics | 424B3:募资说明书
Dianthus Therapeutics | 8-K:重大事件
Dianthus Therapeutics | ARS:年度报告
Dianthus Therapeutics | DEFA14A:其他
Dianthus Therapeutics | DEF 14A:股东委托书决议
Dianthus Therapeutics | SC 13D/A:超过5%持股股东披露文件(修正)-Fairmount Funds Management LLC(9.99%),Fairmount Healthcare Fund II LP(9.99%)等
Dianthus Therapeutics | 4:持股变动声明-董事 Fairmount Funds Management LLC
Dianthus Therapeutics | EFFECT:其他
Dianthus Therapeutics | CORRESP:信函
Dianthus Therapeutics | S-8:员工福利计划证券登记
Dianthus Therapeutics | S-1/A:证券上市注册声明(修正)
Dianthus Therapeutics | 10-K:年度报表
Dianthus Therapeutics | 8-K:重大事件
Dianthus Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Andrew J. Schwab(5.7%),Kush Parmar(5.7%)等
Dianthus Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Third Rock Ventures IV, L.P.(0%),Third Rock Ventures GP IV, L.P.(0%)等
Dianthus Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Citadel Advisors LLC(0.0%),Citadel Advisors Holdings LP(0.0%)等
Dianthus Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-GV 2016, L.P.(1.4%),GV 2016 GP, L.P.(1.4%)等
Dianthus Therapeutics | S-1/A:证券上市注册声明(修正)
Dianthus Therapeutics | CORRESP:信函
暂无数据